A detailed history of Dorsey Wright & Associates transactions in Cabot Corp stock. As of the latest transaction made, Dorsey Wright & Associates holds 35,061 shares of CBT stock, worth $2.87 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
35,061
Holding current value
$2.87 Million
% of portfolio
0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$90.64 - $117.0 $3.18 Million - $4.1 Million
35,061 New
35,061 $3.2 Million
Q2 2023

Jul 26, 2023

SELL
$63.92 - $76.74 $767 - $920
-12 Reduced 0.32%
3,734 $249,000
Q1 2023

Apr 19, 2023

SELL
$65.68 - $83.66 $1,642 - $2,091
-25 Reduced 0.66%
3,746 $287,000
Q4 2022

Feb 14, 2023

BUY
$62.05 - $77.11 $233,990 - $290,781
3,771 New
3,771 $252,000

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $4.61B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.